Medtronic

NYSE MDT · Galway, Ireland

Works in Cardiovascular · Genetic & rare · Musculoskeletal · Neurology · Renal & urogenital · Women's health

Medtronic is a clinical trial sponsor based in Galway, Ireland, listed as NYSE MDT. It has 13 active clinical trials with 206,902 planned participants, across 6 therapeutic areas. Since 2021 it has completed 11 trials and stopped 2 early. Its FDA record on file shows 4 recalls.

Trial track record · since 2021

13Active trials206,902 planned participants
11Completed1 with results posted
2Stopped early15% of finished trials

FDA record

0InspectionsNone posted since 2025
0Warning lettersNone on file
4RecallsLatest 2026-11-04: Class II

Recent FDA actions

Financials · NYSE MDT

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 13 active trials

StageTrialStatus

Questions about Medtronic

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-05.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Approve Suite is not affiliated with Medtronic.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.